ENVB
Enveric Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.69M
P/E Ratio
—
EPS
$-22.74
Beta
1.10
52W High
$17.64
52W Low
$1.50
50-Day MA
$2.65
200-Day MA
$4.89
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
23.09
PEG Ratio
—
About Enveric Biosciences Inc
Enveric Biosciences, Inc., a pharmaceutical company, is dedicated to developing various cannabinoid drugs for the treatment of cancer. The company is headquartered in Naples, Florida.
Fundamentals
| Revenue (TTM) | $35.41M |
| Gross Profit (TTM) | $8.15M |
| EBITDA | $-8.06M |
| Operating Margin | 0.00% |
| Return on Equity | -183.10% |
| Return on Assets | -96.70% |
| Revenue/Share (TTM) | $37.68 |
| Book Value | $2.68 |
| Price-to-Book | 1.32 |
| Price-to-Sales (TTM) | 0.08 |
| EV/Revenue | 1.758 |
| EV/EBITDA | 0.29 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -7.30% |
| Shares Outstanding | $4.03M |
| Float | $3.55M |
| % Insiders | 10.81% |
| % Institutions | 2.78% |
Historical Volatility
HV 10-Day
159.80%
HV 20-Day
125.93%
HV 30-Day
103.84%
HV 60-Day
108.94%
HV Rank
—
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 6/13/2026